undamentalytics Newsletter

Ayers Jonathan W: insider trades

Chief executive, Officer, Director at Idexx Laboratories. No open-market purchases and 40 sales not made under a pre-set plan, reported from March 9, 2010 to May 22, 2023.

What happened after Ayers Jonathan W’s sales?

After their sales, the shares moved +22.4% against the index over 12 months on average (a negative figure means selling was the right call); 18% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Ayers Jonathan W: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 40 +4.4% +8.4% 38% 10 0.17 0.87 No reliable evidence
Sales, 12 months after the report 40 +22.4% +21.8% 18% 10 2.13 0.062 No reliable evidence
Sales, 12 months after the trade 40 +22.3% +23.5% 23% 10 1.96 0.081 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Idexx Laboratories IDXX Chairman of the Board040March 9, 2010May 22, 2023

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
May 22, 2023May 18, 2023 IDXX Sale $9,805,801 +1.7%−16.9%−20.5%
February 17, 2022February 15, 2022 IDXX Sale $127,425 −14.0%+4.0%+6.1%
June 1, 2021May 28, 2021 IDXX Sale $5,318,998 +15.3%−31.2%−28.7%
May 26, 2021May 24, 2021 IDXX Sale $5,495,750 +14.8%−28.5%−28.9%
May 24, 2021May 20, 2021 IDXX Sale $2,685,325 +13.7%−30.2%−27.4%
May 20, 2021May 18, 2021 IDXX Sale $4,029,772 +19.3%−26.1%−30.6%
May 12, 2021May 10, 2021 IDXX Sale $277,000 +21.6%−29.7%−30.8%
February 22, 2021February 18, 2021 IDXX Sale $555,560 −3.9%−19.3%−23.8%
November 10, 2020November 6, 2020 IDXX Sale $3,040,929 +9.0%+3.3%−3.2%
November 6, 2020November 4, 2020 IDXX Sale $12,468,535 +7.9%+10.5%−1.5%
November 4, 2020November 2, 2020 IDXX Sale $8,958,017 −6.0%+0.5%+3.7%
August 24, 2020August 20, 2020 IDXX Sale $6,887,133 +15.5%+43.8%+44.9%
August 20, 2020August 18, 2020 IDXX Sale $7,689,258 +13.4%+41.3%+43.5%
August 18, 2020February 14, 2020 IDXX Sale $17,124,259 +12.1%+46.3%+68.0%
May 20, 2020May 18, 2020 IDXX Sale $11,273,470 +15.8%+41.3%+35.5%
May 13, 2020May 11, 2020 IDXX Sale $14,758,300 +11.9%+31.2%+32.5%
May 12, 2020May 8, 2020 IDXX Sale $6,162,001 +14.2%+33.1%+37.2%
May 8, 2020May 4, 2020 IDXX Sale $11,130,402 +10.7%+32.5%+43.5%
February 24, 2020February 20, 2020 IDXX Sale $6,667,086 +17.1%+79.9%+75.4%
February 21, 2020February 19, 2020 IDXX Sale $11,493,218 +17.1%+72.2%+72.0%
February 20, 2020February 18, 2020 IDXX Sale $11,473,606 +16.3%+74.8%+69.7%
November 14, 2019November 12, 2019 IDXX Sale $9,146,021 +3.0%+56.8%+59.1%
November 12, 2019November 7, 2019 IDXX Sale $9,942,083 +1.6%+56.8%+65.9%
November 6, 2019November 4, 2019 IDXX Sale $21,884,092 −3.0%+65.9%+47.9%
August 12, 2019August 8, 2019 IDXX Sale $2,727,481 −15.9%+19.3%+22.3%
August 7, 2019August 5, 2019 IDXX Sale $5,245,160 −10.2%+22.3%+31.4%
May 6, 2019May 3, 2019 IDXX Sale $6,972,724 +9.7%+14.8%+10.9%
August 23, 2018August 21, 2018 IDXX Sale $7,365,101 −14.8%+12.4%+11.3%
August 30, 2017August 28, 2017 IDXX Sale $1,960,291 −7.0%+43.9%+46.5%
August 16, 2017August 14, 2017 IDXX Sale $8,990,042 −6.3%+40.8%+39.4%
August 10, 2017August 9, 2017 IDXX Sale $2,627,180 −8.1%+39.5%+40.9%
August 9, 2017August 8, 2017 IDXX Sale $2,794,000 −7.5%+42.9%+41.5%
June 1, 2017May 30, 2017 IDXX Sale $2,181,660 −10.3%+14.1%+9.5%
May 11, 2017May 10, 2017 IDXX Sale $4,392,660 −8.9%+12.8%+12.7%
May 8, 2017May 5, 2017 IDXX Sale $4,175,860 −8.3%+12.8%+14.3%
February 23, 2017February 22, 2017 IDXX Sale $4,990,179 +14.4%+10.4%+12.6%
November 30, 2016November 28, 2016 IDXX Sale $3,284,782 +19.9%+12.9%+8.1%
August 4, 2016August 4, 2016 IDXX Sale $6,461,667 +0.2%+26.7%+24.7%
August 19, 2015August 17, 2015 IDXX Sale $1,160,982 −12.7%+37.1%+35.3%
March 9, 2010March 5, 2010 IDXX Sale $2,720,112 +18.5%+21.2%+20.2%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Ayers Jonathan W traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.